These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 33331349)
1. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic. Vadan R; Iacob R; Costache R; Stroie T; Saizu IA; Iacob S; Gheorghe L; Diculescu M; Gheorghe C J Gastrointestin Liver Dis; 2020 Dec; 29(4):549-553. PubMed ID: 33331349 [TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group. Arrigo S; Alvisi P; Banzato C; Bramuzzo M; Celano R; Civitelli F; D'Arcangelo G; Dilillo A; Dipasquale V; Felici E; Fuoti M; Gatti S; Knafelz D; Lionetti P; Mario F; Marseglia A; Martelossi S; Moretti C; Norsa L; Panceri R; Renzo S; Romano C; Romeo E; Strisciuglio C; Martinelli M Dig Liver Dis; 2021 Mar; 53(3):283-288. PubMed ID: 33388247 [TBL] [Abstract][Full Text] [Related]
3. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician. Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 in IBD: The experience of a single tertiary IBD center. Rizzello F; Calabrese C; Salice M; Calandrini L; Privitera H; Melotti L; Peruzzi G; Dussias N; Belluzzi A; Scaioli E; Decorato A; Siniscalchi A; Filippone E; Laureti S; Rottoli M; Poggioli G; Gionchetti P Dig Liver Dis; 2021 Mar; 53(3):271-276. PubMed ID: 33451910 [TBL] [Abstract][Full Text] [Related]
5. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic. El Ouali S; Rubin DT; Cohen BL; Regueiro MD; Rieder F Curr Opin Gastroenterol; 2021 Jul; 37(4):313-319. PubMed ID: 33859104 [TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future. Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749 [TBL] [Abstract][Full Text] [Related]
7. Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment. Wauters L; Billiet T; Papamichael K; Ballet V; Joniau S; Verschueren P; Silversmit G; Van Assche G; Vermeire S; Ferrante M Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):84-90. PubMed ID: 27603297 [TBL] [Abstract][Full Text] [Related]
8. Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD. Selinger CP; Fraser A; Collins P; Gunn M; Chew TS; Kerry G; Patel KV; Roysam M; Bel Kok K; Bancil A; Hall V; Cooney R; Smith L; Steed H; Segal J; Kent A; Limdi J; Sebastian S BMJ Open Gastroenterol; 2021 Mar; 8(1):. PubMed ID: 33753426 [TBL] [Abstract][Full Text] [Related]
9. Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic. Iborra I; Puig M; Marín L; Calafat M; Cañete F; Quiñones C; González-González L; Cardona G; Mañosa M; Domènech E Dig Dis Sci; 2021 Dec; 66(12):4191-4196. PubMed ID: 33469807 [TBL] [Abstract][Full Text] [Related]
10. Safety of biologics in inflammatory bowel disease patients with COVID-19. Weissman S; Aziz M; Smith WL; Elias S; Swaminath A; Feuerstein JD Int J Colorectal Dis; 2021 Sep; 36(9):2051-2055. PubMed ID: 34131784 [TBL] [Abstract][Full Text] [Related]
11. Expanding telehealth options during the COVID pandemic eliminated racial and age disparities in electronic communication by inflammatory bowel disease patients. Hayrapetian L; Zepp M; Rao S; Hennessey M; Houle M; Atienza M; Belfaqeeh OA; Dharia I; Khan A; Borum ML J Natl Med Assoc; 2021 Aug; 113(4):474-477. PubMed ID: 33941370 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy. Berte' R; Mazza S; Stefanucci MR; Noviello D; Costa S; Ciafardini C; Mileti E; Mapelli M; Pasqualato S; Pinto S; Favale A; Vecchi M; Neurath MF; Atreya R; Fantini MC; Facciotti F; Caprioli F J Crohns Colitis; 2021 May; 15(5):864-868. PubMed ID: 33211810 [TBL] [Abstract][Full Text] [Related]
13. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. Saibeni S; Scucchi L; Dragoni G; Bezzio C; Miranda A; Ribaldone DG; Bertani A; Bossa F; Allocca M; Buda A; Mocci G; Soriano A; Mazzuoli S; Bertani L; Baccini F; Loddo E; Privitera AC; Sartini A; Viscido A; Grossi L; Casini V; Gerardi V; Ascolani M; Ruscio MD; Casella G; Savarino E; Stradella D; Pumpo R; Cortelezzi CC; Daperno M; Ciardo V; Nardone OM; Caprioli F; Vitale G; Cappello M; Comberlato M; Alvisi P; Festa S; Campigotto M; Bodini G; Balestrieri P; Viola A; Pugliese D; Armuzzi A; Fantini MC; Fiorino G; United European Gastroenterol J; 2020 Dec; 8(10):1228-1235. PubMed ID: 33070758 [TBL] [Abstract][Full Text] [Related]
14. Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases. Brenner EJ; Pigneur B; Focht G; Zhang X; Ungaro RC; Colombel JF; Turner D; Kappelman MD; Ruemmele FM Clin Gastroenterol Hepatol; 2021 Feb; 19(2):394-396.e5. PubMed ID: 33059040 [TBL] [Abstract][Full Text] [Related]
15. Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. Guerra I; Algaba A; Jiménez L; Mar Aller M; Garza D; Bonillo D; Molina Esteban LM; Bermejo F Inflamm Bowel Dis; 2021 Jan; 27(1):25-33. PubMed ID: 32830267 [TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 on diagnosis and management of paediatric inflammatory bowel disease during lockdown: a UK nationwide study. Ashton JJ; Kammermeier J; Spray C; Russell RK; Hansen R; Howarth LJ; Torrente F; Deb P; Renji E; Muhammed R; Paul T; Kiparissi F; Epstein J; Lawson M; Hope B; Zamvar V; Narula P; Kadir A; Devadason D; Bhavsar H; Beattie RM Arch Dis Child; 2020 Dec; 105(12):1186-1191. PubMed ID: 32732316 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 and inflammatory bowel disease: A pathophysiological assessment. Yang C; Xiao SY Biomed Pharmacother; 2021 Mar; 135():111233. PubMed ID: 33433350 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 in patients with inflammatory bowel disease. Anikhindi SA; Kumar A; Arora A Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1187-1193. PubMed ID: 32856955 [TBL] [Abstract][Full Text] [Related]
19. Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the COVID-19 pandemic. Shah R; Wright E; Tambakis G; Holmes J; Thompson A; Connell W; Lust M; Niewiadomski O; Kamm M; Basnayake C; Ding J Intern Med J; 2021 Jul; 51(7):1038-1042. PubMed ID: 34278693 [TBL] [Abstract][Full Text] [Related]
20. Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy. Ardizzone S; Ferretti F; Monico MC; Carvalhas Gabrielli AM; Carmagnola S; Bezzio C; Saibeni S; Bosani M; Caprioli F; Mazza S; Casini V; Cortelezzi CC; Parravicini M; Cassinotti A; Cosimo P; Indriolo A; Di Sabatino A; Lenti MV; Pastorelli L; Conforti F; Ricci C; Sarzi-Puttini P; Vecchi M; Maconi G J Gastroenterol Hepatol; 2021 Nov; 36(11):3050-3055. PubMed ID: 34159648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]